Lesson plan
Taraxein
Taraxein is a possibly nonexistent protein isolated from the blood of patients with schizophrenia, claimed by Robert Galbraith Heath to produce schizophrenia-like symptoms when injected into healthy subjects. Despite initial interest, attempts at confirmation failed. The results are today commonly assumed to be due to self-deception. The name is derived from the Greek word τάραξις (taraxis), meaning disordered or confused mind. Taraxein was discovered during the investigation of the hypothesis that catecholamine metabolism is altered in schizophrenia. A blue substance was found in extracts from people with schizophrenia but not normal, and it was claimed that when tested on monkeys this produced the abnormal septal activity the experimenters thought was characteristic of schizophrenia. At the 1956 annual meeting of the American Psychiatric Association Heath announced that they "had induced full symptoms of schizophrenia" in two nonpsychotic prisoner-volunteers from Louisiana State Penitentiary. This was followed by claims of successful induction of symptoms characteristic of schizophrenia in further subjects. The announcement caught the interest of the popular press and the scientific community. However, the latter was concerned with both the double-blind procedure, the claimed total lack of placebo effect, and a failure by an outside team to replicate the findings.…
Article summary
Taraxein is a possibly nonexistent protein isolated from the blood of patients with schizophrenia, claimed by Robert Galbraith Heath to produce schizophrenia-like symptoms when injected into healthy subjects. Despite initial interest, attempts at confirmation failed. The results are today commonly assumed to be due to self-deception. The name is derived from the Greek word τάραξις (taraxis), meaning disordered or confused mind. Taraxein was discovered during the investigation of the hypothesis that catecholamine metabolism is altered in schizophrenia. A blue substance was found in extracts from people with schizophrenia but not normal, and it was claimed that when tested on monkeys this produced the abnormal septal activity the experimenters thought was characteristic of schizophrenia. At the 1956 annual meeting of the American Psychiatric Association Heath announced that they "had induced full symptoms of schizophrenia" in two nonpsychotic prisoner-volunteers from Louisiana State Penitentiary. This was followed by claims of successful induction of symptoms characteristic of schizophrenia in further subjects. The announcement caught the interest of the popular press and the scientific community. However, the latter was concerned with both the double-blind procedure, the claimed total lack of placebo effect, and a failure by an outside team to replicate the findings.…
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.